Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) Cash from Investing Activities (QoQ) (2010 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 1,576.03%
Jun 30, 2025 72.27%
Mar 31, 2025 -101.59%
Dec 31, 2024 71.78%
Sep 30, 2024 -318.54%
Jun 30, 2024 28.78%
Mar 31, 2024 70.86%
Dec 31, 2023 50.32%
Sep 30, 2023 -1,081.73%
Jun 30, 2023 97.74%
Mar 31, 2023 -4,028.20%
Dec 31, 2022 14.23%
Sep 30, 2022 -93.70%
Jun 30, 2022 35.04%
Mar 31, 2022 34.29%
Dec 31, 2021 -74.49%
Sep 30, 2021 27.60%
Jun 30, 2021 2.48%
Mar 31, 2021 15.26%
Dec 31, 2020 -241.32%
Sep 30, 2020 57.40%
Jun 30, 2020 -124.00%
Mar 31, 2020 54.19%
Dec 31, 2019 -235.09%
Sep 30, 2019 -400.00%
Jun 30, 2019 144.19%
Mar 31, 2019 72.26%
Dec 31, 2018 -234.20%
Sep 30, 2018 248.08%
Jun 30, 2018 -18.18%
Mar 31, 2018 13.16%
Dec 31, 2017 60.82%
Sep 30, 2017 48.81%
Jun 30, 2017 -144.52%
Mar 31, 2017 -16.49%
Dec 31, 2016 77.46%
Sep 30, 2016 28.47%
Jun 30, 2016 39.29%
Mar 31, 2016 -1,285.37%
Dec 31, 2015 99.73%
Sep 30, 2015 -338,204.56%
Jun 30, 2015 33.01%
Mar 31, 2015 72.56%
Dec 31, 2014 -16.36%
Sep 30, 2014 -68.11%
Jun 30, 2014 -219.57%
Mar 31, 2014 62.10%
Dec 31, 2013 6.95%
Sep 30, 2013 52.35%
Jun 30, 2013 76.51%
Mar 31, 2013 22.94%
Dec 31, 2012 -79.13%
Sep 30, 2012 33.80%
Jun 30, 2012 -50.41%
Mar 31, 2012 16.88%
Dec 31, 2011 -88.83%
Sep 30, 2011 -45.70%
Jun 30, 2011 32.58%
Mar 31, 2011 41.28%
Dec 31, 2010 -34.03%